Our December Issue contains Reviews on the seminal microbiome, improving clinical trials in urological oncology, tissue engineering for penile erectile regeneration and the mechanism of action of 223Ra in mCRPC.

This issue includes a Review on precision oncology in advanced prostate cancer and a Perspective on landmarks in the development of vaginal mesh.

The October issue has Reviews on urogenital tuberculosis, the multifaceted immune regulation of bladder cancer and optimizing pharmacokinetics of intravesical chemotherapy for bladder cancer.

This issue includes Reviews on pelvic radiotherapy in prostate cancer, findings and implications of TCGA for RCC, physical activity for erectile dysfunction and organ preservation in bladder cancer.

Our August issue includes Reviews on regenerative and engineered options for urethroplasty, long non-coding RNAs in genitourinary malignancies and molecular and histopathological evidence for pathology-driven therapy for advanced bladder cancer.

This Issue includes Reviews on machine learning in prostate cancer and bacteriophages of the urinary tract and a Perspective on galectins prostate and bladder cancer.

This Issue includes a Consensus Statement on using blue light flexible cystoscopy in NMIBC and Reviews on metabolomic urinary cancer biomarkers and using the stem cell secretome in regenerative urology.

Our May Issue includes Reviews on BRCA2 mutations in prostate cancer, MIF family proteins in genitourinary cancer, ambulatory urodynamic monitoring and new-age biomarkers and nanodiagnostics in prostate cancer.

This issue includes Reviews on Zika virus in the male genital tract, epigenetic drugs in TGCT and radiation exposure for CT imaging in nephrourology.

In this Issue Stephen Fry and Ben Challacombe discuss the patient and the surgeon view of prostate cancer.

This issue is a special Focus Issue on sexual medicine, including articles on sexuality and sexual function in transgender persons and stem cell therapy for penile fibrosis.

This issue includes reviews on T1 bladder cancer, identifying rare cells in liquid biopsies for prostate cancer, infection stones, and urinary extravasation after high-grade renal trauma.